Cargando…
An Early Adverse Drug Event Detection Approach with False Discovery Rate Control
Adverse drug event (ADE) is a significant challenge in clinical practice. Many ADEs have not been identified timely after the approval of the corresponding drugs. Despite the use of drug similarity network demonstrates early success on improving ADE detection, false discovery rate (FDR) control rema...
Autores principales: | Shi, Yi, Peng, Xueqiao, Liu, Ruoqi, Sun, Anna, Yang, Yuedi, Zhang, Ping, Zhang, Pengyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312832/ https://www.ncbi.nlm.nih.gov/pubmed/37398083 http://dx.doi.org/10.1101/2023.05.31.23290792 |
Ejemplares similares
-
Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
por: Liu, Ruoqi, et al.
Publicado: (2019) -
Three‐Component Mixture Model‐Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System
por: Zhang, Pengyue, et al.
Publicado: (2018) -
False discovery rates in spectral identification
por: Jeong, Kyowon, et al.
Publicado: (2012) -
Controlling the Rate of GWAS False Discoveries
por: Brzyski, Damian, et al.
Publicado: (2017) -
A unified approach to false discovery rate estimation
por: Strimmer, Korbinian
Publicado: (2008)